UROwebinar: From molecular environment to theranostics in hormone sensitive prostate cancer

This UROwebinar will present data from one of the biggest PCa biomarker repository platform in the world; unravel new potential radioligands for a finer characterisation of the disease; and also discuss the outlook of theranostic in hormone-sensitive setting.
Tue, 5 Mar 2024
WebinarProstate CancerOncology
Organiser European School of Urology
CME 1.00
Location Online

Prostate cancer (PCa) is a heterogeneous neoplasm with different molecular signature profiles. Their identification is among the most difficult challenges in current research, but their clinical implications are broad. These encompass the discovery of new biomarkers in blood, urine or tissue samples, the expansion of radioligands for molecular imaging diagnosis and staging, and the development of targeted treatments including theranostic.

UROwebinar in collaboration with the EAU Section of Urological Imaging (ESUI) and the EAU Section of Urological Research (ESUR).


Ass. Prof. D. Oprea-Lager (NL)
Prof. K.A. Tasken (NO)
Prof. F. Sanguedolce (ES)
Dr. J. Lindberg (SE)
Dr. D. S. S. Scherr (US)

Contact our organiser

European School of Urology

Email:  esu@uroweb.org